IAR-037

N/A

Report date: 2025/06/04 14:33:17
First In Class

Base Information

Drug NameIAR-037
Drug Alias NameIAR037IAR-037
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 modulatorsProgrammed death-ligand 1 modulators
TargetsTumor necrosis factor receptor superfamily member 5Programmed death-ligand 1
Therapy Area/IndicationsSolid tumoursImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInnovent Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnovent Biologics IncInnovent Biologics Technology Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A